{"timestamp": 1771603631.2364345, "value": {"ticker": "MBRX", "company_name": "Moleculin Biotech, Inc.", "short_name": "Moleculin Biotech, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 7821241, "float_shares": 2007074, "shares_outstanding": 3079229, "short_ratio": 3.18, "short_percent_of_float": 0.14140001, "shares_short": 429080, "shares_short_prior": 171538, "insider_percent_held": 0.01663, "institution_percent_held": 0.05889, "total_cash": 6703000, "total_debt": 390000, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 0, "current_ratio": 1.388, "book_value": -13.596, "price_to_book": -0.18681966, "operating_cashflow": -22452000, "free_cashflow": -12177125, "price": 2.54, "52w_high": 55.5, "52w_low": 2.49, "avg_volume": 287639, "avg_volume_10d": 70380, "full_time_employees": 17, "audit_risk": 0, "overall_risk": 0}}